SCI Abstract

search
+
Health disparities in neurology
Health disparities in neurology
Health disparities are preventable differences in health between different populations, and they are endemic thro...
Non-invasive brain stimulation: current and future applications in neurology
Non-invasive brain stimulation: current and future applications in neurology
Device-based non-invasive brain stimulation (NIBS) techniques show promise for the treatment of neurological and psychiatr...
A paradigm shift away from dissemination in time in multiple sclerosis
In the 2024 revisions of the McDonald criteria for diagnosis of multiple sclerosis (MS), dissemination in time is no longe...
The 2024 revisions of the McDonald criteria pose risk of multiple sclerosis overdiagnosis
The 2024 revisions of the McDonald criteria for multiple sclerosis for the first time permit diagnosis in asymptomatic peo...
Implementation of the 2024 revision of the McDonald criteria for multiple sclerosis
Implementation of the 2024 revision of the McDonald criteria for multiple sclerosis
The 2024 revision of the McDonald criteria for diagnosis of multiple sclerosis marks a substantial departure from previous...
The multiple sclerosis prodrome: insights into how and when disease starts
The multiple sclerosis (MS) prodrome and radiologically isolated syndrome (RIS) form overlapping parts of the MS disease c...
Progress and challenges in sporadic late-onset cerebellar ataxias
Progress and challenges in sporadic late-onset cerebellar ataxias
Sporadic late-onset cerebellar ataxia (SLOCA) is a syndrome defined by subacute or chronic and progressive ataxia occurrin...
Myotonic dystrophy type 1: clinical diversity, molecular insights and therapeutic perspectives
Myotonic dystrophy type 1: clinical diversity, molecular insights and therapeutic perspectives
Myotonic dystrophy type 1 (DM1) is the most prevalent muscular dystrophy in adulthood and is one of the most clinically di...
Markers help to predict dementia with Lewy bodies
Biomarkers of Alzheimer disease (AD) pathology can predict the development of dementia with Lewy bodies (DLB) in people wi...
MS drug beneficial in an underrepresented group
Real-world data indicate that ocrelizumab is safe and effective in Latino people with multiple sclerosis (MS), according t...
Exploring the long-term neurological consequences of COVID-19
Exploring the long-term neurological consequences of COVID-19
Two recently published studies have provided new insights into the long-term effects of COVID-19 on the nervous system.
Neuron–tumour networks targeted
Characterization of the networks formed between neurons and glioblastoma cells enables targeting of these networks with th...
Imperatives and co-benefits of research into climate change and neurological disease
Imperatives and co-benefits of research into climate change and neurological disease
Evidence suggests that anthropogenic climate change is accelerating and is affecting human health globally. Despite urgent...
The impact of rare genetic variants on Alzheimer disease
The impact of rare genetic variants on Alzheimer disease
Alzheimer disease (AD) is a progressive neurodegenerative disease with a strong genetic component. Although autosomal domi...
Nothing about us, without us — establishing a patient and public involvement and engagement group
Nothing about us, without us — establishing a patient and public involvement and engagement group
Implementation of patient and public involvement and engagement (PPIE) to enable patients and carers to feel included and ...
Moving towards meaningful patient and public engagement
Patient and public involvement and engagement is increasingly mandated in funding applications, yet often remain tokenisti...
Improved quality of life with MS treatment
Cladribine tablets can improve quality of life in people with highly active relapsing multiple sclerosis (MS), according t...
IGFBP2 levels associated with Alzheimer disease
A study published in Brain has found correlations between serum and cerebrospinal fluid levels of insulin-like growth fact...
A multiple hits hypothesis for memory dysfunction in Parkinson disease
A multiple hits hypothesis for memory dysfunction in Parkinson disease
Cognitive disorders are increasingly recognized in Parkinson disease (PD), even in early disease stages, and memory is one...
Restoring synaptic plasticity after stroke
Gamma oscillations induced by optogenetic stimulation restore functional synaptic plasticity in a mouse model of stroke, a...
CD11c+ macrophages mediate brain-to-gut α-synuclein trafficking
CD11c+ macrophages mediate brain-to-gut α-synuclein trafficking
New research indicates that in a mouse model of Parkinson disease, α-synuclein is trafficked from the brain to the gu...
ALS pathogenesis linked to actin barrier collapse
Repulsive guidance molecule A (RGMa) regulates actin dynamics via neogenin 1 signalling. A new study found that the cerebr...
A tale of race and B cells in multiple sclerosis
A new study indicates that African American people with multiple sclerosis have higher markers of humoral disease patholog...
Rare genetic brain disorders with overlapping neurological and psychiatric phenotypes
Rare genetic brain disorders with overlapping neurological and psychiatric phenotypes
Understanding rare genetic brain disorders with overlapping neurological and psychiatric phenotypes is of increasing impor...
A new biological classification for Parkinson disease
In a plenary lecture at the XXVI World Congress of Neurology, Anthony Lang presented a new biological classification model...
Metformin protects against dementia in diabetes
Use of metformin in people aged ≥60 years with type 2 diabetes mellitus (T2DM) is associated with a reduced risk of develo...
Glioblastoma tackled with oncolytic virus
A first-in-human trial indicates that treatment with an oncolytic virus is associated with increased survival in people wi...
Myelination mediates benefits of ketamine
Restoration of impaired myelination underlies the long-lasting antidepressant effects of ketamine, new research suggests. ...
Peripheral B cells altered in Parkinson disease
The findings of an immunophenotyping study suggest that abnormal peripheral B cell responses could contribute to Parkinson...
Biomarkers in amyotrophic lateral sclerosis: current status and future prospects
Biomarkers in amyotrophic lateral sclerosis: current status and future prospects
Disease heterogeneity in amyotrophic lateral sclerosis poses a substantial challenge in drug development. Categorization b...
Load More
format_indent_increase